European Patients' Academy on Therapeutic Innovation
The European Patients’ Academy on Therapeutic Innovation (EUPATI) provides education and training for patients and patient representatives on the process of medicines research and development (R&D). The trained patient experts are key to realising meaningful patient engagement in medicines R&D, regulatory deliberations and other activities.
EUPATI was established by the Innovative Medicines Initiative (IMI) in 2012, and was hosted by the European Patients’ Forum (EPF) as a Public-Private Partnership Programme 2017-2020.
EUPATI is today established as an independent non-profit Foundation in the Netherlands and has 24 National Platforms in Europe and in Japan.
“We focus on education and training to increase the capacity and capability of patients to be valuable contributors to medicines research and development by working with patients and the stakeholders they collaborate with.”
European Patients' Academy
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Servier Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Servier Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Other 17 Dec 2019 | | |
Bayer Pharmaceutical, Chemistry, Chemical Manufacturing | Bayer Pharmaceutical, Chemistry, Chemical Manufacturing | Other 15 Dec 2021 | | |
Eurostat European Union, Environmental Services | Eurostat European Union, Environmental Services | Other 8 Oct 2019 | | |
Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Other 16 Sep 2021 | |